Catherine Owen Adams Appointed CEO of Acadia Pharmaceuticals
Slice of Healthcare Team
Sep 24, 2024
Key Highlights
- Catherine Owen Adams appointed CEO, succeeding Steve Davis.
- Adams brings extensive global experience from Bristol Myers Squibb and Johnson & Johnson.
- Acadia advances treatments for Parkinson’s disease psychosis and Rett syndrome.
- Adams aims to accelerate growth, innovation, and new partnerships.
Source: Business Wire
Notable Quotes
“ Catherine is a proven global leader with a distinguished record of accomplishment of driving growth and innovation in the pharmaceutical industry. ”
Stephen Biggar, M.D., Ph.D., Chair of the Board of Directors at Acadia Pharmaceuticals
“ I am thrilled to join Acadia at such a pivotal and dynamic time for the company. ”
Catherine Owen Adams, CEO at Acadia Pharmaceuticals
“ Catherine’s deep commercial and global expertise is a perfect fit to execute on Acadia’s mission. ”
Steve Davis, Former CEO at Acadia Pharmaceuticals
Heading
Hims & Hers Launches $99 GLP-1 Subscriptions for U.S. Service Heroes News Product News Read More Chris-Anne Roque Matthias Evers, Ph.D., Joins IMIDomics’ Board of Directors Hiring News News Read More Chris-Anne Roque CorriXR Therapeutics Appoints Jill Castilla to Board of Directors Hiring News News Read More Chris-Anne Roque Komodo Health Launches AI-Powered Tools: MapAI™ and MapExplorer™ News Product News Read More Chris-Anne Roque Aura Launches At-Home Health Check in New York, Offering Unmatched Convenience News Product News Read More Chris-Anne Roque August Health Introduces Billing & Payments Solution for Senior Living Operators News Product News Read More Chris-Anne Roque
